Clinical Trials Logo

Critical Illness clinical trials

View clinical trials related to Critical Illness.

Filter by:

NCT ID: NCT00178321 Withdrawn - Critically Ill Clinical Trials

Improving Sleep in the Pediatric Intensive Care Unit

Start date: September 2005
Phase: N/A
Study type: Interventional

Sleep is disrupted in the PICU. This disruption has been reported in studies that have used: (a) observation of sleep-wake cycles (b) self-reports by children themselves , and (c) objective measures (e.g., electroencephalograph( EEG). Noise and light levels have been correlated with profound sleep disruption in the PICU . Sleep disruption is known to have a profound impact on the overall health of a child, both from a physiological and a psychological standpoint . In addition, sleep disruption has been shown to change cortisol levels, cause impaired immune responses and impair cognitive function in both children and adults . Disruption in sleep also is known to impair healing through these many complex connections with other homeostatic processes in the human body. What is the effect of wearing earplugs in critically ill children admitted to the PICU on: 1. Sleep states 2. Physiological stability (e.g. melatonin, cortisol and immune status) 3. Sleep habits after discharge from the PICU (on the general pediatric unit, 2 weeks and 2 months after discharge), and 4. Child behavior at 2 weeks and 2 months after discharge from the PICU by parent report on the Child Behavior Checklist (CBCL).

NCT ID: NCT00176306 Completed - Obesity Clinical Trials

Levofloxacin Pharmacokinetics (PK) in the Severely Obese

Start date: January 2005
Phase: Phase 4
Study type: Interventional

Obesity is known to affect the concentrations of certain medications in the body. Levofloxacin is a commonly used antibiotic. Based on what the investigators know about levofloxacin and how it moves through the body, obesity may affect levofloxacin concentrations. This study aims to show the effect of obesity on levofloxacin concentrations. The hypothesis is as follows: A 750 mg intravenous (IV) dose of levofloxacin administered to severely obese, critically ill patients will yield serum concentrations that are likely to be therapeutic.

NCT ID: NCT00167596 Terminated - Critical Illness Clinical Trials

Near Infrared Spectroscopy (NIRS) in Severe Sepsis

OTO-STS
Start date: July 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the usefulness of an optimization of muscle perfusion and oxygenation, as assessed by the NIRS technique, in critically ill patients with sepsis.

NCT ID: NCT00167440 Withdrawn - Low Cardiac Output Clinical Trials

Comparison of Techniques for Assessing Cardiac Output and Preload in Critically Ill Pediatric Patients

Start date: August 2004
Phase: Phase 3
Study type: Observational

Each year in the United States more than 30,000 children are admitted to intensive care units. The majority of these children have some degree of heart instability during their stay, yet there is currently no routine way to measure the actual amount of blood that the heart pumps. The ability to measure the amount of blood that the heart pumps accurately and easily at frequent intervals would be very helpful to the doctor caring for these children because many of them have poor heart function as a result of their illnesses. Current techniques used in adults to measure output of the heart are either not readily transferred to children or demand difficult invasive procedures. Because of this, the amount of blood that the heart pumps cannot be measured with enough frequency to help guide care. Despite this reality, accurate measurements of the amount of blood that the heart pumps in these patients at crucial points in their illnesses would allow for more accurate use of potentially harmful procedures and could possibly improve the outlook for these children. Likewise, being able to correctly measure blood volume could provide a better way to estimate the pressure on the heart and improve treatment. The purpose of this research study is to compare the accuracy of doctor estimates of heart output, and establish the usefulness of central blood volume measurements by PCOM (pediatric cardiac output measurements), a less invasive procedure

NCT ID: NCT00166491 Completed - Critical Illness Clinical Trials

Comparing Two Ways of Controlling Blood Sugar With Insulin in Patients Admitted to the Intensive Care Unit

Start date: July 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if there is any difference between two ways of controlling blood sugar with insulin. In patients admitted to the intensive care unit, blood sugar levels often rise due to the stress of illness or surgery. Studies have shown that patients do better if their blood sugar is kept normal. In order to maintain normal blood sugar levels, the investigators often give insulin (a substance made by the body), and they decide how much to give based on how high the blood sugar is. This study will compare two different ways of deciding how much insulin to give and compare how well each method keeps the blood sugar in a normal range. Both ways of controlling blood sugar are institutionally-approved protocols and part of routine care.

NCT ID: NCT00163813 Not yet recruiting - Critical Illness Clinical Trials

The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study

ENTERIC
Start date: n/a
Phase: N/A
Study type: Interventional

This is a multi-centre randomised controlled trial comparing early jejunal feeding (using a frictional nasojejunal [NJ] tube) and standard feeding in critical illness.

NCT ID: NCT00156767 Completed - Clinical trials for Adrenal Insufficiency

Adrenal Function in Critical Illness

Start date: November 12, 2004
Phase:
Study type: Observational

An appropriate hypothalamic-pituitary-adrenal (HPA) axis response is required to survive critical illness. Primary adrenal insufficiency, relative adrenal insufficiency, tissue resistance to glucocorticoids, ACTH deficiency and immune-mediated inhibition of the HPA axis may impair the secretion or action of glucocorticoids in critically ill patients. Adrenal insufficiency is estimated to occur in up to 77% of critically ill patients, but currently, there is no consensus on the diagnostic criteria for adrenal insufficiency in this setting, and standard testing does not discriminate among the aforementioned factors. We will study the incidence and natural history of adrenal insufficiency in critically ill patients to further define adrenal insufficiency and provide data to develop diagnostic tests. Clinical features and outcomes will be correlated with laboratory measurements of hormones, cytokines and glucocorticoid action. Healthy volunteers will undergo cortrosyn tests with measurement of free cortisol levels to develop a normative range for this endpoint. <TAB> Previous glucocorticoid use, if prolonged and supraphysiologic, also inhibits the HPA and can result in adrenal insufficiency. Patients with short intermittent courses of glucocorticoid administration have not been studied well, and may also be at risk. To gain further information about this group, patients receiving pulse glucocorticoid doses as part of bone marrow transplant regimens at the Clinical Center will also be studied. ...

NCT ID: NCT00144638 Completed - Clinical trials for Sepsis - to Reduce Mortality in the Intensive Care Unit

Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality

Start date: January 2002
Phase: N/A
Study type: Observational

Procalcitonin, a marker of infection has often been compared to clinical pictures as for instance "clinical sepsis". This has given som problems in the interpretation of these studies, because of the lack of good Gold Standards for "clinical sepsis. We have decided to investigate the development from day to day of Procalcitonin in the blood of intensive care patients, compared to the mortality. Hypothesis: Procalcitonin increase after reaching a certain level predicts mortality in the Intensive Care Unit.

NCT ID: NCT00143494 Completed - Clinical trials for Critically Ill Patients

The Estimation of Abdominal Pressure by the Bladder and Gastric Pressure

Start date: July 2005
Phase: N/A
Study type: Interventional

The investigators aim to compare the bladder pressure to the gastric pressure in critically ill patients.

NCT ID: NCT00142220 Completed - Sepsis Syndrome Clinical Trials

The Benefit of Adding Fish Oil to the Nutrition of Critically Ill Patients

Start date: January 2004
Phase: Phase 4
Study type: Interventional

We study whether an increased proportion of omega-3-fatty acids (contained in fish oil) in the nutrition of critically ill patients reduces systemic inflammation.